Cardiovascular disease (CD) is a major burden for Western society. Regenerative medicine has provided encouraging results, yet it has not addressed the focal defects causing CD and mainly related to the inefficient repair programme of the heart. In this scenario, stem cells have been broadly investigated and their paracrine effect proposed as a...
-
2017 (v1)PublicationUploaded on: March 27, 2023
-
March 23, 2018 (v1)Publication
Human amniotic fluid stem cells (hAFS) are immature fetal mesenchymal progenitors with promising paracrine potential, as previously shown by a study in a preclinical rat model of ischemia/reperfusion injury. Nevertheless, little is known about the comprehensive analysis of their secretome, which is represented by the whole of soluble secreted...
Uploaded on: March 27, 2023 -
2016 (v1)Publication
The anthracycline doxorubicin (Dox) is widely used in oncology, but it may cause a cardiomyopathy with bleak prognosis that cannot be effectively prevented. The secretome of human amniotic fluid-derived stem cells (hAFS) has previously been demonstrated to significantly reduce ischemic cardiac damage. Here it is shown that, following hypoxic...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
Human amniotic fluid stem cells (hAFS) have shown a distinct secretory profile and significant regenerative potential in several preclinical models of disease. Nevertheless, little is known about the detailed characterization of their secretome. Herein we show for the first time that hAFS actively release extracellular vesicles (EV) endowed...
Uploaded on: April 14, 2023